Showing 1 - 1 results of 1 for search 'John S. Wesolowski', query time: 0.02s
Refine Results
-
1
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies by Samantha M. Goodstal, Jing Lin, Timothy Crandall, Lindsey Crowley, Andrew T. Bender, Albertina Pereira, Maria Soloviev, John S. Wesolowski, Riham Iadevaia, Sven-Eric Schelhorn, Edith Ross, Federica Morandi, Jianguo Ma, Anderson Clark
Published 2023-11-01
Article